HEPARIN SODIUM INJECTION, created in 2000 (United States), from 1125 sister brands and 17478 competing brands. HEPARIN SODIUM INJECTION is owned by Pfizer Inc, listed on the stock exchange of New York HEPARIN SODIUM INJECTION is part of the Drug Manufacturers activity sector.